CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.82 Cr | ₹1.96 Cr | ₹2.30 Cr | ₹1.87 Cr | ₹2.10 Cr |
What is the latest Long Term Provisions ratio of CONCORD BIOTECH ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.82 Cr |
| Mar2024 | ₹1.96 Cr |
| Mar2023 | ₹2.30 Cr |
| Mar2022 | ₹1.87 Cr |
| Mar2021 | ₹2.10 Cr |
How is Long Term Provisions of CONCORD BIOTECH Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.82 Cr | 44.17 | |
| Mar2024 | ₹1.96 Cr | -14.85 | |
| Mar2023 | ₹2.30 Cr | 22.57 | |
| Mar2022 | ₹1.87 Cr | -10.68 | |
| Mar2021 | ₹2.10 Cr | - | |
Compare Long Term Provisions of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,036.8 Cr | -4.7% | -7.1% | -41.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -4.7% |
-7.1% |
-41.8% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses